CEPIA

Trademark usage description

treatment of chemical product specifically, chemicals for use the pharmaceutical industry, namely, custom manufacture and custom synthesis of chemical Read More

Classification Information

Class [040]
Treatment of chemical product specifically, chemicals for use the pharmaceutical industry, namely, custom manufacture and custom synthesis of chemicals for use in the pharmaceutical industry; treatment of bio-organic preparations for use in the field of pharmaceuticals, namely, custom manufacture and custom synthesis of bio-organic preparations for use in the field of pharmaceuticals, treatment of monoclonal antibodies and pharmaceutical preparations, namely, custom manufacture and custom synthesis of monoclonal antibodies and pharmaceutical preparations

Classification kind code

Class [042]
Research and development services in the field of pharmaceuticals, namely research for the development of new active ingredients; pharmaceutical research services, namely identifying the industrial synthesis of pharmaceutical preparations and manufacturing; realization and conception of analysis methods in the bio-organic pharmaceutical and chemical industries; development and studies of analytic methods to control chemical reactions, namely, quality control services for the manufacture of pharmaceutical products and their chemical reactions

Classification kind code

Mark Details

Serial Number

1813198

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 9^th Nov 2018	Allowed
Submitted for opposition 51 on 9^th Nov 2018	Allowance Notice Sent
Submitted for opposition 42 on 25^th Jul 2018	Advertised
Submitted for opposition 26 on 5^th Jul 2018	Approved
Submitted for opposition 27 on 15^th May 2018	Approval Notice Sent
Submitted for opposition 22 on 29^th Aug 2017	Search Recorded
Submitted for opposition 20 on 29^th Aug 2017	Examiner's First Report
Submitted for opposition 31 on 12^th Dec 2016	Formalized
Submitted for opposition 30 on 8^th Dec 2016	Filed
Submitted for opposition 1 on 8^th Dec 2016	Created